Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adults

NICE technology appraisals [TA245] Published date:

NICE recommends apixaban as a possible treatment to reduce the risk of venous thromboembolism in adults.

Who can have apixaban?

You should be able to have apixaban if you have had surgery to replace your hip or knee.

Why has NICE said this?

NICE looks at how well treatments work, and also at how well they work in relation to how much they cost the NHS. NICE recommended apixaban because it works better and costs less than one of the most commonly used drugs available on the NHS that is used to reduce the risk of thromboembolism.

Get involved